fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,122 recalls, newest first.
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Lack of assurance of sterility:
Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.
Microbial contamination of Non-Sterile Product; presence of yeast identified as Candida parapsilosis
Subpotent: Out of Specification result observed for low assay
Incorrect/Undeclared Excipients.
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility